International Paper (IP) Q4 2025 earnings review
IP Announces Major Split and $2.5B Impairment as Profit Momentum Reverses
International Paper (IP) reported Q4 results dominated by two stories: a massive $2.47 billion non-cash goodwill impairment charge related to the EMEA segment (DS Smith acquisition), and the strategic decision to split the company into two independent North American and EMEA packaging solutions entities. While Adjusted Operating Loss of $(43) million improved sequentially, Adjusted EBITDA reversed direction, decelerating 11.7% QoQ to $758 million. The sequential profitability drop was driven by a catastrophic collapse in the EMEA segment, which posted an operating loss of $(223) million. Despite the turmoil, the company issued FY26 Adjusted EBITDA guidance of $3.5–$3.7 billion, signaling a projected 21% recovery driven purely by internal cost control and restructuring benefits.
🐂 Bull Case
The planned separation of North America and EMEA segments into two independent companies is a decisive action to unlock value. It forces focused management, tailored capital allocation, and addresses the underperformance of the merged DS Smith/legacy EMEA unit via simplification.
Packaging Solutions North America (PS NA) operating profit reversed massive Q3 losses to deliver $319 million in Q4, signaling that previous cost-out actions and market share gains are taking hold and creating an advantaged cost position.
Free Cash Flow jumped to $255 million in Q4, reversing the full-year FCF loss of $(159) million and validating management's emphasis on working capital and disciplined capital spending.
🐻 Bear Case
The $2.47 billion goodwill impairment charge confirms the DS Smith combination has failed to deliver anticipated value, and the underlying business is structurally weak. PS EMEA operating loss deteriorated sharply to $(223) million.
The company’s recovery hinges on flawless execution of the $600 million incremental cost-out target for 2026. Given the complexity of the European restructuring (works councils, plant closures) and the internal upheaval associated with the corporate split, execution risk is high.
⚖️ Verdict: 🔴
Bearish. While the North American segment is recovering and the strategic separation is positive, the non-cash impairment is a clear admission of failure on the DS Smith integration. The sharp sequential drop in Adjusted EBITDA and the deteriorating profitability in EMEA raise major operational concerns heading into the split.
Key Themes
$2.47 Billion Goodwill Impairment in PS EMEA
IP recorded a pre-tax, non-cash goodwill impairment charge of $2.47 billion in Q4 2025 related entirely to the Packaging Solutions EMEA segment. This charge, which drove the massive GAAP loss, follows the strategic decision to separate the company into two independent entities, confirming that the value of the combined DS Smith/legacy EMEA business is far below its carrying cost due to persistent market softness and challenging integration.
Strategic Separation into Two Focused Companies
IP intends to form two independent, public packaging solutions companies (PS NA and PS EMEA) within 12–15 months. This action aims to create focused management teams, tailored investment strategies, and compelling financial profiles for each region. This separation is highly material and fundamentally alters the investment thesis, moving IP away from a single global packaging leader to two regional pure-plays.
PS EMEA Operating Profit Collapsed
PS EMEA operating profit reversed aggressively, accelerating its loss from $(58) million in Q3 to $(223) million in Q4. This collapse occurred despite sales being relatively stable sequentially. Management cited lower sales prices and volumes in a soft demand environment, along with higher depreciation ($73M accelerated D&A) due to valuation finalization post-acquisition. This weakness is structural and highlights significant challenges in stabilizing the European business ahead of the split.
North America Performance Rebounds
PS NA operating profit posted a strong recovery to $319 million in Q4 2025, rebounding from the significant loss in Q3 (caused by accelerated D&A charges). YoY operating profit improved nearly 40%. The results validate management’s claim that strategic customer wins and cost-out initiatives are driving above-market growth and delivering positive operating leverage in the second half.
Aggressive Cost-Out Actions Fueling 2026 Guidance
Management continues to emphasize that the 2026 guidance is driven entirely by self-help. Actions taken throughout 2025 (mill closures, organizational overhead reductions, 80/20 deployment) are expected to deliver approximately $600 million of incremental Adjusted EBITDA benefit in 2026. This aggressive approach is essential, as the guidance assumes no benefit from future market or price recovery.
Sequential Operational Momentum Decelerates
Adjusted EBITDA fell 11.7% sequentially from $859 million in Q3 to $758 million in Q4. This deceleration runs counter to the previous narrative of strong operational ramp-up expected in H2, indicating that market softness and EMEA operational issues overwhelmed the cost-out benefits realized in North America during the quarter.
Other KPIs
The full-year GAAP loss was primarily driven by the $2.47 billion non-cash goodwill impairment charge related to PS EMEA and $0.96 billion in accelerated depreciation associated with asset rationalization decisions (mill closures). Adjusting for these items reveals an Adjusted Operating Loss of $(100) million for the full year.
Q4 FCF accelerated sharply, increasing 70% sequentially from $150 million in Q3 and resulting in positive liquidity for the quarter. However, FCF for the full year remains negative at $(159) million, missing the previously guided positive range (Q3 guidance was $(100M) to $(300M)). The Q4 spike in operating cash flow ($905M) was essential for achieving this positive quarterly result.
IP incurred $626 million in restructuring charges in FY25, highlighting the aggressive execution of the 80/20 strategy and mill closure actions throughout the year. These charges, while significant cash costs upfront, underpin the $600 million incremental EBITDA benefit expected in FY26.
Guidance
Accelerating. The midpoint of $3.6 billion implies a 21.0% growth rate compared to FY25 Adjusted EBITDA ($2.976B). This acceleration is solely dependent on the flow-through of 2025 cost-out actions and synergies, not on market recovery or pricing gains.
Stable/Slight Deceleration. The midpoint of $750 million implies a -1.0% sequential change compared to Q4 2025 ($758M). This suggests that Q1 will be primarily flat, confirming the continued expectation of operational stability before further cost-out actions ramp up later in the year.
Key Questions
EMEA Restructuring Costs and Timeline
Given the massive impairment charge and the Q4 collapse to a $(223) million operating loss in PS EMEA, what is the updated expected cost and timeline for the regional restructuring and facility closures needed to stabilize the business before the proposed spin-off?
Execution Risk of the Split
What are the estimated separation costs, and how will IP manage the significant internal disruption of splitting the company into two entities (especially concerning IT, corporate functions, and the 12-15 month timeline) while simultaneously executing the aggressive $600 million cost-out plan?
Pricing Assumptions for 2026
Management stated 2026 targets do not reflect future price realization. Can you confirm if Q1 2026 revenue is expected to be flat or decline sequentially, and what specific pricing index movements, if any, are assumed in the full-year $3.6 billion EBITDA midpoint?